$363.23
-2.1%HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Chief Executive Officer & Director
Compensation
$6,846,331
Chief Financial Officer & Executive Vice President
Compensation
$2,381,758
Executive Vice President & Chief Clinical Officer
Compensation
$2,911,023
Executive Vice President & Chief Operating Officer
Compensation
$3,555,267
Executive Vice President and Chief Legal & Administrative Officer
Compensation
$2,955,500
Founder & Chairman Emeritus
Compensation
$17,973
Senior Vice President & Chief Information Officer
Senior Vice President, Chief Ethics & Compliance Officer
Senior Vice President, Principal Accounting Officer & Controller
Vice President of Investor Relations
During the last 12 months, insiders have sold $16.54M worth of HCA shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
25.9K
13.09M
-13.1M
-$13.09M
0
0.00
7.7K
3.45M
-3.5M
-$3.45M
0
0.00
0
0.00
+0
+$0
No buying activity
Hazen Samuel N
Director, Officer: Ceo
$7.40M
Mcalevey Michael R
Officer: Evp & Chief Legal & Admin Off.
$2.75M
Cuffe Michael S.
Officer: Evp And Chief Clinical Officer
$2.35M
Wyatt Christopher F.
Officer: Svp & Controller
$2.02M
Berres Jennifer
Officer: Svp & Chief Human Res. Officer
$2.02M
Strong bearish signal with $16.54M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
HCA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 13, 2026 | April 23, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 14, 2025 | April 24, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 15, 2024 | April 25, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 10, 2023 | March 10, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 11, 2022 | April 21, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 19, 2021 | April 28, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 20, 2020 | May 01, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 15, 2019 | April 26, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 16, 2018 | April 26, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 17, 2017 | April 27, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.